Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
-
Identify and recall eligible patients Who is eligible for a shingles vaccination under the National Immunisation Programme?
For more information on Immunocompromised individuals please visit our dedicated hub
For more information on the eligibility criteria for the Shingles National Immunisation Programme please explore the Greenbook chapter 28a.
Ensure you are identifying and recalling ALL patients eligible for a shingles vaccination using your call and recall system.
Illuminate, GSK’s dedicated community-driven platform designed by Immunisation Leads is here to support you as you deliver national immunisation programmes including shingles. Visit illuminate for more information on implementing the programme.
-
Set up shingles vaccination clinics Are you running dedicated clinics to vaccinate your patients against shingles? Or perhaps you could find gaps in existing clinics? Are there ways you could make vaccination as easy as possible with coffee mornings, community centres or mid week clinics? Visit illuminate now to learn from experts who are effectively implementing the Shingles National Immunisation Programme.
Illuminate, GSK’s dedicated community-driven platform designed by Immunisation Leads for healthcare professionals is here to support you as you deliver the Shingles National Immunisation Programme.
-
Order shingles vaccines All vaccines for the Shingles National Immunisation Programme are centrally procured and available to order through ImmForm.
Ensure your GP surgery has sufficient vaccines for your planned clinics plus sufficient vaccines should there be an opportunity for opportunistic vaccination.
-
Ensure second dose compliance SHINGRIX is given as a 2 dose schedule. The GreenBook guidance for administration of the second dose as part of the National Immunisation Programme differs from the SmPC
Ensure you are vaccinating your patients with their second dose by using your call/recall system to invite them
-
Raise awareness with patients Ensure members of the public are aware of the programme, their eligibility for vaccination and the potential risks of shingles
GSK have a range of programme awareness materials available to order including posters and leaflets.
Raising awareness with patients using printed and digital materials is an essential step when implementing the programme.
GSK also have a range of materials specifically to support healthcare professionals when discussing shingles and the national programme with patients.
-
Hear from the experts Hear from the experts
Register for upcoming webinars, or view on-demand recordings of past events to answer your questions and hear best practice on implementing the shingles national immunisation programme.
References:
- The GreenBook chapter 28a – Shingles. July 2023
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
SHINGRIX is owned by or licensed to the GSK group of companies.
© 2023 GSK group of companies or its licensor.
Trade marks are owned by or licensed to the GSK group of companies.
November 2023 | PM-GB-SGX-WCNT-230025(V2.0)
